UC Davis Health Ventures
Overview
UC Davis Health Ventures is the corporate venture capital arm and commercialization hub of UC Davis Health, investing in and translating research into market-ready solutions across healthcare and life sciences.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Delix Therapeutics | Sep 2025 | Strategic | Lead |
| SurvivorPlan | Feb 2024 | Accelerator | Co-investor |
| Molecular Matrix, Inc. | Jan 2018 | Angel | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is UC Davis Health Ventures based?
UC Davis Health Ventures is headquartered in Sacramento, California, United States.
When was UC Davis Health Ventures founded?
UC Davis Health Ventures was founded in 2025.
How many portfolio companies does UC Davis Health Ventures have?
UC Davis Health Ventures has 3 portfolio companies in Caplight's dataset.
What are some companies in UC Davis Health Ventures's portfolio?
Recent investments visible on Caplight include Delix Therapeutics, SurvivorPlan, Molecular Matrix, Inc..
What was UC Davis Health Ventures's most recent investment?
UC Davis Health Ventures's most recent investment on Caplight was in Delix Therapeutics in 2025.
What sectors does UC Davis Health Ventures focus on?
UC Davis Health Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does UC Davis Health Ventures focus on?
UC Davis Health Ventures typically invests at the Early stage.
What is UC Davis Health Ventures's AUM?
UC Davis Health Ventures's assets under management are estimated between $25.0M and $25.0M.